






Pharmaceuticals can cause serious hazardous effects on the aquatic environment. Humans that are being treated with the drugs often excrete the hazardous pharmaceuticals that are of interest in this paper. Wastewater treatment plants are unable to completely remove the pharmaceuticals from the water and thus the fish downstream of the sewage effluents are the most likely to be affected. The following steroid estrogens and non-steroidal anti-inflammatory drugs (NSAIDs) have serious effects on wild fish: 17-estradiol, estrone, and 17-ethinylestradiol, and diclofenac. The steroid estrogen pharmaceuticals have been proven to cause sexual disruption in a variety of wild fish including: roach fish, white suckers, and zebra fish. The NSAIDs have been proven to cause major histological effects that lead to organ failure in other wild fish species, including the rainbow trout. The public health importance of studying these hazardous pharmaceutical and their effects on the ecosystem is necessary to determine long-term effects and potential hazardous effects to humans. 

TABLE OF CONTENTS
 TOC \o "2-4" \h \z \t "Heading 1,1,Appendix,1,Heading,1" 1.0	Introduction	1
2.0	PHARMACEUTICAL REMOVAL AND DISPOSAL	3
2.1	EPA STANDARDS	4
3.0	ENDOCRINE DISRUPTING COMPOUNDS	5
3.1	WHITE SUCKERS CASE STUDY	6
3.2	ZEBRA FISH CASE STUDY	9
3.3	ROACH FISH CASE STUDY	10
4.0	NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDs)	12
4.1	RAINBOW TROUT CASE STUDY	13




Table 1 Pharmaceutical effect in different tissues and matrices in fish ………………………….2
Table 2 Intersex scale …………………………………………………………………………...11

List of figures
Figure 1 White Sucker Fish at Boulder Creek sample site (downstream) ……………………….8









In recent years, there has been growing concern about hazardous pharmaceutical waste reaching the ecosystem. The EPA exacerbating potential environmental impact does not mandate regulation of disposal of household pharmaceuticals. Nonetheless, there are numerous case studies determining specific effects of such pharmaceutical waste on aquatic biota and attempting to quantify risk to fish and ultimately human health. 

Although pharmaceuticals are developed to exert selective biological effects when used therapeutically in man, when released in the environment, they can retain their biological activities and produce a myriad of untoward effects in unintended recipients.  A prime example of such unintentional effects is the feminization and sexual disruption of male fish exposed to discarded steroid estrogens and non-steroidal anti-inflammatory drugs (NSAID)  (1). Steroid estrogens are important members of large family of potential toxic compounds referred to as Endocrine Disrupting Compounds (EDCs). The effects of EDC are not limited to fish but extend to the entire ecosystem and aquatic biota (2) and ultimately to man. 

There is no indication of what the specific risks of EDCs and the anti-inflammatory pharmaceuticals pose to humans once they are in the water. There are however many recent case studies evaluating the risk to the ecosystem (2). The overall consensus of recent studies is that EDCs and anti-inflammatory pharmaceuticals in the ecosystem act in a way that can disrupt the sexual and reproductive systems in fish. Specifically the disruptions can cause feminization and intersex fish (see table 1 for specific effects). For purposes of this paper, intersex is defined by the presence of developing oocytes within the testicular tissue and/or an ovarian cavity in addition to a sperm duct. (3).

Table 1 Pharmaceutical effect in different tissues and matrices in fish
		PHARMACEUTICAL	MEDICATION CLASS	FISH MATRIXAFFECTED	EFFECTSOBSERVED
17- Estradiol	Steroid estrogen/ hormone	Muscle	Estrogenic activity
17- Ethinylestradiol	Steroid estrogen/ hormone	Homogenate	Estrogenic activity
Estrone	Steroid estrogen/ hormone	Muscle, homogenate	Estrogenic activity
Diclofenac	NSAID	Muscle, liver, kidney, gills, bile, blood	Renal lesions, gill alteration, tubular neurosis, villi fusion in intestine, 
Ibuprofen	NSAID	Blood, bile, muscle, liver, kidney, gills, digestive glands	Effects on gene expression

2.0 	PHARMACEUTICAL REMOVAL AND DISPOSAL
There is a lot of public confusion and misconceptions about proper disposal of pharmaceuticals. The Environmental Protection Agency (EPA), U.S. Drug Enforcement Administration (DEA) local law enforcement agencies, and pharmacies participate in National Take-Back Day.  This voluntary approach allows public to dispose of unwanted or expired pharmaceuticals and it is processed as municipal solid waste in accordance with local and state environmental agency requirements. It is usually disposed at municipal solid waste or hazardous waste incinerators. While the state and local environmental agencies establish regulations for its proper disposal, the EPA suggests that all pharmaceutical waste collected at these events be disposed of as hazardous waste (4).





In 2008, the EPA outlined a proposal that would add hazardous waste pharmaceuticals to the Universal Waste Program. Ultimately, the EPA decided not to implement the proposal due to negative public comments regarding lack of notification of the proposal and the current burdensome tracking requirements under the Universal Waste Program. The EPA decided to develop new standards a for disposal of hazardous waste pharmaceuticals that are generated by healthcare-related facilities. The new proposal was limited to pharmaceutical waste that is generated by health care related facility and meets the definition of RCRA (Resource Conservation and Recovery Act) hazardous waste. The RCRA was enacted in the 1970s. A key exemption under the RCRA is for households. Under this exemption, any pharmaceutical waste that is generated by households is not required to be disposed of or managed in accordance with federal hazardous waste regulations. This also applies to pharmaceutical waste generated by a household that is collected at a take-back event (4).
3.0 	ENDOCRINE DISRUPTING COMPOUNDS 
Endocrine Disrupting Compounds are compounds that interfere at potentially numerous steps (synthesis, release, metabolism, biological effects) in hormone-mediated processes. . Pertinent to this discussion, EDCs can cause sexual developmental problems such as feminization (4, 13). EDCs have been observed at concentrations sufficient to disrupt reproductive physiology in both estuarine and freshwater fish (3). The following factors contribute to varying concentration levels of EDCs in the water: fluctuation of wastewater flow, treatment efficacy, seasonal use of medications, time of day, time of week, time of year, human population, and seasonal hydrologic conditions (2). Another major factor that contributes to the toxicity of EDCs is the proximity to waste water treatment plants (WWTP) effluent discharges. 
Steroid estrogens are said to be the most common and significant estrogenic measureable compound found in sewage effluents. Steroid estrogens are also commonly detected in these sewage effluents due to their human origin. According to Jobling et. AL. 2006 although concentrations of the steroid estrogens are low, highly potent molecules including 17-estradiol, estrone, and 17-ethinylestradiol exerts biological effects in this range and such concentrations (6) are sufficient to induce intersex change in some fish species (3). Even when the concentrations of these steroid estrogens are below the lowest observable effect concentration (LOEC), mixtures of these pharmaceuticals can still cause an effect (3, 7).

17-estradiol and estrone are natural steroid estrogens excreted by humans. The steroid estrogen 17-ethinylestradiol is used in contraceptive pills and in hormone replacement therapy. Since humans excrete these steroid estrogens, their appearance at WWTP is predictable and the amount is related to human activity associated with such WWTP. The amount of steroid estrogen excreted will vary by age, sex, and whether a female is pregnant. Published data from 2004 indicates that removal efficiencies at WWTP for steroid estrogens 17-estradiol, estrone, and 17-ethinylestradiol are 82, 65, and 85% respectively (3).
3.1	WHITE SUCKERS CASE STUDY

In Colorado, two rivers were selected to examine intersex fish and other disruptions in reproductive physiology. Boulder Creek and the South Platte River were both selected because they were located downstream of wastewater treatment plants. Wastewater treatment plant (WWTP) effluents are known to contain steroid estrogens and other compounds that induce intersex in some species of fish (8).

White suckers (Catostomus commersoni) were selected because it is a species that widely inhabits the rivers and streams of Colorado. The sample sites for Boulder Creek and the South Platte River were sampled at 50m and 3km downstream of their respective WWTP. There were also reference sites at each location that were upstream of the respective WWTP (8). Boulder Creek white suckers were sampled during the spring and fall of 2002. The white suckers in the South Platte River were collected in May of 2002 (8).

At the Boulder Creek location, the white suckers were removed from the rivers and anesthetized with MS 222 and the gonads were removed and examined. In the spring of 2002 there were a total of 22 white suckers removed from the site that was downstream of the WWTP. There were 20 female white suckers collected and one male collected. At the reference site upstream, there were five male white suckers and seven females collected.  In the fall of 2002, there were a total of 39 white suckers removed from the downstream site. There were 30 females collected, four intersex fish, four males, and one fish had no identifiable gonad tissue. During this time, 20 white suckers were collected from the reference site upstream. Of the 20 fish collected, nine were male, 10 were female, and one had no identifiable gonadal tissue (8). Of the four intersex fish collected, they were all two years of age or older (see figure 1). During examination of the gonads, spermatogenetic cysts were scattered in a disorganized manner. There was also highly fibrotic tissue that contained oogonia and malformed pre-vitellogenic oocytes (8).

At the South Platte River location, 20 white suckers were collected at the downstream sample site. Sixteen of the collected white suckers were identified as female and the other four were identified as intersex. The four-intersex fish were all greater than two years of age like the white suckers collected at the Boulder Creek sample site. The intersex condition varied among the four-intersex fish. In two of the fish, the gonads were fibrotic with scattered oocytes (see figure 2). While the oocytes compromised anywhere between 30-50% of the gonadal tissue, the remainder of the tissue was in various stages of spermatogenetic development (8). Similar to the Boulder Creek location, six white suckers were collected at the reference sample site in the South Platte River. None of these white suckers were intersex (8).










Figure 1 White Sucker Fish at Boulder Creek sample site (downstream)


Figure 2 White Sucker Fish at South Platte River sample site (downstream)
3.2	ZEBRA FISH CASE STUDY

Most of the studies that examine the effects of steroid estrogens are done in the natural habitats of the wildlife. Nash et AL. 2004. studied the effects of steroid estrogens on zebrafish that were bred for at least one generation in the laboratory. The study began with 720 adult zebrafish of both male and female sex placed in 60 aquaria. The fish were exposed to steroid estrogens in the aquarium and the number of eggs was determined (6).

 prior to steroid estrogen exposure and after. In the period prior to exposure, there was not a significant difference in number of eggs in the five groups. There were also no noted differences in reproductive output. After short-term exposure of steroid estrogens, there was a reduction in egg production in the five groups. After ten days of exposure, there was complete reproductive failure in the zebrafish, and the treatment stopped. 

The case study concluded that different reproductive components have different sensitivities to the steroid estrogens. The sensitivities can depend on the length of exposure and the timing of the exposure in relation to maturity and sexual development. There was a strong impact of the length of exposure on the stimulation of VTG. Life-long exposures in the F1 adults showed no apparent VTG stimulation whereas; short-term exposures in the F0 generation strongly stimulated VTG (6).
3.3	ROACH FISH CASE STUDY

A 2002 case study in the United Kingdom (UK) focused on steroid estrogen levels in roach fish in UK Rivers.  A range of 45 low-risk, medium-risk, and high-risk sites were selected around the UK. A predictive model determined the risk of potential sites. The abundance of roach fish in the area of the site as well as existence of data on sewage discharges also influenced site selection. Each site was defined as a 2 km section around the sewage discharge (1 km upstream of the discharge and 1 km downstream of the discharge). The number of fish collected at each site varied between 10-60 male and female roach fish (3).

The roach fish were caught and killed with an overdose of the anesthetic MS-222. The length, weight, and gonadal weight of each roach fish were determined. The gonads from each roach fish collected were cut into 3 sections (anterior, mid, and posterior) to be further examined. Any abnormalities in sexual development were noted as well as abnormal reproductive ducts and germ cells (3). The researchers defined the severity of the condition in intersex fish by using a numerical scale from 0-7, where 0 was all testis tissue and 7 (see table 2) was all ovarian tissue. Researchers also made predictions at each location based on the individual concentrations of each of the following steroid estrogens (17-estradiol, estrone, and 17-ethinylestradiol). Once the individual levels were evaluated, it was predicted that with the exception of estrone, the concentrations were not high enough to be sufficient evidence to cause feminization in the roach fish at most locations. However, once the concentrations were combined using equivalent concentrations, many more locations were predicted to cause the disruptions in the roach fish (3). 

Once the research was evaluated, it was determined that intersex roach fish were found at all of the high-risk and medium-risk sites. Intersex fish were also found at low-risk sites but in a lower frequency. The number of intersex fish found was directly proportional to the predicted exposure of the fish to steroid estrogens. It was also determined that feminization occurred earlier in life in the roach fish and that it was a progressive condition. In conclusion, the results of this case study suggested that concentrations of steroid estrogens in the rivers in the United Kingdom is most likely a strong contributing cause of intersex in wild fish populations (3).

Table 2 Intersex Score
Score 0	Normal male testis
Score 1	1-5 oocytes scattered in testicular tissue
Score 2	6-20 oocytes scattered in testicular tissue (usually in small clusters)
Score 3	21-50 oocytes scattered in testicular tissue (usually in larger clusters)
Score 4	More than 50 but less than 100 oocytes, has mosaic of testicular and ovarian tissue
Score 5	More than 100 oocytes, clearly identifiable zones of ovarian and testicular tissue
Score 6	50% of gonad tissue is ovarian and clearly separated from testicular tissue by epithelial cells
Score 7	100% of gonad tissue is ovarian

4.0 	NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDs)
NSAIDs (non-steroidal anti-inflammatory drugs) are a large class of chemically diverse drugs that are analgesic, anti-pyretic and anti-inflammatory. Synthesis of aspirin (and subsequently acetaminophen and numerous other agents) and their utility in diverse and common disorders (rheumatoid arthritis, ischemic heart disease, management of pain and fever) have made these relatively inexpensive agents ubiquitous (approximately 35 tons of aspirin alone is consumed per day in US) in pharmacotherapy.  Their mechanism of action (as well as adverse effects) in large part is inhibition of cyclooxygenase with subsequent reduction in biosynthesis of oxygenated fatty acids including prostaglandins, thromboxane and prostacyclin.  

In light of the prodigious use of NSAIDs, it is not surprising that discarded unused compounds or excreted metabolites can appear in water and ecosystem.  Like humans, NSAIDs can be toxic to intestine, kidney and liver of fish as well as their gills (9).  The data that is available about the presence of pharmaceutical residues that are found in the environment are mostly limited to the parent compound and oftentimes overlook the potentially larger contribution of their metabolites (10). The specific NSAID evaluated for the purpose of this paper is diclofenac.  Similar to the steroid estrogens, diclofenac is not completely removed by WWTP. Also as with steroid estrogens, the studies involving diclofenac focused primarily on fish (9).

4.1	RAINBOW TROUT CASE STUDY

The effects of diclofenac were studied in rainbow trout (oncorhynchus mykiss) that were about two years of age over the course of 28 days. The trout were exposed to different levels of diclofenac (1, 5, 20, 100, and 500). There were two groups of trout studied, the control group and the exposed group. After the 28-day time period, fish were anaesthetized for further evaluation. Tissue samples from the left gills, middle portion of the posterior kidney, anterior portion of the liver, and a portion of the gut were collected from the fish. The tissue samples were cut into pieces of 1-2 mm and assessed. Each set of tissues from the different organs was examined individually and in further detail (9). The overall health status of each of the organs was also noted. 

Hepatocytes, cellular compartmentation, cytoplasm, nuclei, endoplasmic reticulum, Golgi apparatus, mitochondria, peroxisomes, lysosomes, glycogen/lipid storage, macrophage infiltration, and other cellular debris were further assessed in the liver tissue. The rainbow trout that had been exposed to diclofenac showed prominent collapse of the cellular compartmentation and significant glycogen depletion. In places where glycogen was formerly stored, membrane material was found instead. The endoplasmic reticulum was examined and it was found to be degranulated (9).

Eight different sections of the kidney that were further evaluated. Also investigated were: renal corpuscles, anterior and posterior sections of the proximal tubules, distal tubules, cytoplasm, nuclei, Golgi apparatus, endoplasmic reticulum, mitochondria, cell bases, vesicles, and pinocytosis activity. The rainbow trout exposed to diclofenac showed thickening of the basal laminae. The endoplasmic reticulum was similarly dilated and vesiculated (9).

Less conclusive results were found in the gills and intestines of the rainbow trout. In the gills, primary filaments as well as secondary lamellae were examined and assessed. The secondary lamellae in the gills were the most affected portion. There was a severe lifting of the epithelial cells. The main focus of examination in the intestine was epithelial cells and mucocytes. There were 10 sections of the intestine evaluated per fish. The intercellular spaces in the epithelial cells were found to be heavily dilated in the trout that were exposed to diclofenac. The responses in the mucocytes were also stronger in the rainbow trout that were exposed (9).

The overall conclusion from this study is that diclofenac does in fact have significant effects on wild fish, specifically the rainbow trout. The diclofenac showed significant cellular reactions in the liver that activate the metabolism of the fish. The examination of the gills and kidney found that there was deterioration of functional units in each of the organs. The study of the tissues in the intestine did not provide statistically significant conclusions (9).


5.0 	FUTURE STUDIES AND PREVENTION
It is evident that more research needs to be completed to determine the full range of effects that pharmaceuticals can have on the ecosystem. This paper largely focuses on the effects of steroid estrogens and anti-inflammatory pharmaceuticals on fish. It is still unknown the full range of effects that these pharmaceuticals can have on humans and their presence in drinking water. Humans excrete most of the steroid estrogens, thus it is hard to put restrictions in place. A study by Calza et Al. 2012 determined that 70-80% of contamination of these steroid estrogens is excreted from treated patients (11). The levels of concentrations of steroid estrogens at a certain site are found to be relative to the proximity of the site to WWTP. 

Future studies need to focus on the WWTP and new removal systems to eliminate the presence of pharmaceutical contaminants. It is hard to develop a new process to help eliminate these pharmaceuticals when there is not a decisive limit on the concentration levels that are acceptable. There is also a lack in relevant studies that focus on the effects of the pharmaceutical waste on other parts of the aquatic environment. A more invasive study needs to be competed to examine levels of these contaminants in the sediment. Other future studies need to examine a wider range of pharmaceuticals. Multiple studies have started to examine other potential hazardous pharmaceuticals, but there is not enough research complete to determine true significance. Some notable pharmaceuticals needing further evaluation are carbamazepine, lincomycin, and clarithromycin (11). Antidepressants are also a widely prescribed and used class of pharmaceuticals, but little is know about their effect on the aquatic environment. Once again, these contaminates are introduced into the water by human excretion (12). 

6.0 	SUMMARY AND CONCLUSIONS
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